Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.

Synbioven Limited investment portfolio

Synbioven Limited has made numerous investments in companies such as Resurrect Bio, Scindo, and Colorifix within the Biotech sector.

unknown
Portfolio
7
Team
0

Ownership Chain

Sign up free to see the Persons with Significant Control resolved from Companies House.

Sign up free

Portfolio (7)

CompanySectorCitySourceLast confirmed on
Bitrobius Genetics Ltd
Bitrobius Genetics develops the Gentrafix™ platform, a plasmid‑based technology that delivers therapeutic DNA to every affected cell through intercellular transmission, aiming to treat genetic diseases, including those caused by mitochondrial gene mutations. The company targets the gene‑therapy market for diseases that currently have no effective treatments.
Healthcare & Life SciencesMacclesfieldConfirmed2025-11-23
Colorifix Limited
COLORIFIX LIMITED develops a biological dyeing technology that uses genetically engineered bacteria to produce and fix pigments onto textiles, offering an eco-friendly alternative to traditional chemical-based dyeing processes. The company primarily targets the textile and fashion industry, including global brands and manufacturers, with additional partnerships in cosmetics and homewares.
Professional ServicesNorwichConfirmed2026-03-30

Sign up to see the full portfolio

+5 more companies

Sign up

Shareholding changes (7)

Synbioven Limited's positions across portfolio companies
2026

Sign up free to see when this investor has bought or sold shares.

+5 more changes

Sign up

Articles (2)